0      0

JL1111EH - JL1111EH: Managing Infections, Hypogammaglobulinemia, and Neutropenia During Treatment With Teclistamab in Relapsed/Refractory Multiple Myeloma: Nurse-Led Experience From the MajesTEC-1 Study

‐ Nov 2, 2023 2:00pm

Full author listing

Donna Catamero1, Patricia Blázquez Benito2, Samantha Shenoy3, Katherine Chastain4, Arnob Banerjee5, Keqin Qi6, Sheri Skerget,5 Margaret Doyle7, Sandy Kruyswijk8

1Mount Sinai Health System, New York, NY, USA; 2University Hospital of Salamanca, Salamanca, Spain; 3University of California, San Francisco, San Francisco, CA, USA; 4Janssen Research & Development, Raritan, NJ, USA; 5Janssen Research & Development, Spring House, PA, USA; 6Janssen Research & Development, Titusville, NJ, USA; 7Janssen Sciences Ireland, Dublin, Ireland; 8Amsterdam University Medical Center, Amsterdam, The Netherlands


You must be logged in and own this session in order to post comments.